Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 50%Low 0 · 0%Moderate 0 · 0%High 1 · 50%

Mechanical ventilation for RSV infection · patients at high risk of severe respiratory syncytial virus infection

Palivizumab leads to higher mechanical ventilation for RSV infection compared with motavizumab (high certainty).

1 finding from 1 review

Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children 2013 · Cochrane Headline outcomes only
RR 3.79 [1.26, 11.42]
2 studies · 7870 participants
High

Mechanical ventilation for RSV infection · patients at high risk of severe respiratory syncytial virus infection

It is very uncertain whether palivizumab changes mechanical ventilation for RSV infection compared with placebo (very low certainty).

1 finding from 1 review

Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children 2013 · Cochrane Headline outcomes only
RR 1.1 [0.2, 6.09]
2 studies · 2789 participants
Very low